KalVista Corp (KALV) - Operating Sales Margin

KalVista Pharma (KALV) - corporate logo

KalVista Pharmaceuticals is developing partnerships with specialized medical professionals to improve the therapy of rare pathologies. The company aims to capture the hereditary angioedema treatment market by introducing sebetralstat, the first oral drug. The transition to the commercial phase creates an independent revenue growth vector. The level of operational efficiency demonstrates current dynamics, where the -14220.90 metric determines this level.

KALV: KalVista Pharmaceuticals, Inc. Profitability of Operations 07/04/2022 - 06/21/2026

Financial and market metric breakdowns for KalVista Pharmaceuticals (KALV)

Basic company analysis:KalVista Pharmaceuticals Inc
Brand item of KalVista Corp

KalVista Pharmaceuticals (KALV) is transitioning from the development stage to the commercialization of oral treatments for HAE. An analysis of the company's operating margins on GURU.Markets allows for an assessment of the efficiency of fixed cost management. This metric is calculated as the ratio of operating profit to revenue, excluding the impact of taxes and debt service. Growth in this indicator would confirm the scalability of the business with minimal capital expenditures. Positive momentum will serve as a guarantee of the asset's fundamental stability.

Competitor analysis for KalVista Pharmaceuticals

ARGX (argenx N.V.) - Operating Margin|Operating Return on Sales BioNTech Pharma BNTX|Operating Sales Margin ABVX (ABIVAX)|Operating Margin ADMA Biologics, Inc. (ADMA)|Operating Margin PTGX (protagonist-inc.com)|IMVT: Return on Sales by Operating Profit|KNSA - Operating Profitability|GRFS: Operating Profitability|ADPT (Adaptive Biotechnologies) - Operating Sales Margin|Return on Sales by Operating Profit CLDX|Operating Sales Margin AUPH|BCRX (BioCryst Pharmaceuticals) - Operating Profit Ratio|Operating Profitability Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operating Profit Rate|Pharvaris N.V. - Operating Sales Margin|Operating Profit Rate ABCL|TRML: Operating Sales Margin|PGEN (Precigen) - Return on Sales by Operating Profit|pharming.com (PHAR) - Operating Profitability|Nektar Corp (NKTR) - Operating Margin|UPB (upstreambio.com) - Operating Margin|ZBIO: Operating Profit Rate|Operating Margin IMNM|Profitability of Operations Gossamer Bio Inc|Operating Profitability Septerna SEPN|Pieris Pharmaceuticals (PVLA) - Operating Return on Sales|SVRA - Operating Profitability|Rigel Pharmaceuticals - Operating Profit Ratio|AnaptysBio Corp (ANAB) - Operating Profitability|ATXS - Profitability of Operations|Operating Profitability enGene Holdings Inc.|RAPT: Operating Profit Rate|Operating Margin JBIO|Operating Sales Margin aclaristx.com ACRS|Operating Profitability Kyverna Therapeutics Inc. KYTX|Tiziana Life Sciences Ltd. (TLSA) - Operating Return on Sales|Cabaletta Bio, Inc - Operating Margin|Operating Return on Sales Ventyx Biosciences|THTX (theratech.com) - Operating Sales Margin|Operating Sales Margin Avalo Therapeutics, Inc|ELDN (Eledon Pharmaceuticals, Inc) - Operating Margin|Operating Return on Sales Agenus Inc. AGEN|Operating Sales Margin CLYM (Climb Bio, Inc.)|ZURA (Zura Bio Ltd) - Operating Profit Rate|Operating Profitability atyrpharma.com ATYR|Operating Margin Adagene Corp ADAG|IMA - Operating Profitability|Operating Profit Rate STTK (Shattuck Labs)|EQ: Operating Margin|Connect Biopharma (CNTB) - Operating Margin|Operating Profitability Immunic|Operating Margin atarabio.com|Operating Margin IFRX|Operating Margin X4 Pharma (XFOR)|Operating Margin ACET (adicetbio.com)|Operating Margin Celularity Inc. CELU|INMB - Operating Profitability|Operating Profit Rate BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Operating Sales Margin|Operating Sales Margin SAB Biotherapeutics Inc.|Operating Sales Margin AKTX|Operating Sales Margin enlivex.com (ENLV)|Operating Profitability Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operating Profitability Margin|Operating Margin EDSA (Edesa Biotech Corp)|Profitability of Operations iBio (IBIO)|CARM - Operating Profitability|XTL Biopharmaceuticals (XTLB) - Operating Sales Margin|BOLT: Operating Margin|Operating Sales Margin HCW Biologics Inc.|Operating Profitability Aptevo|Return on Sales by Operating Profit AIM (AIM ImmunoTech, Inc.)|Operating Margin ADTX|Profitability of Operations GRI Bio Corp|Operating Margin XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Operating Return on Sales|Revelation Biosciences Corp - Operating Margin|INDP (Indaptus Therapeutics, Inc.) - Return on Sales by Operating Profit|SCNI: Operating Margin|CALI - Profitability of Operations|AFMD (Affimed N.V.) - Operating Margin|Operating Profitability ALLK|Operating Sales Margin HOOK (HOOKIPA Pharma, Inc.)|IGMS - Operating Return on Sales|Operating Profitability iTeos ITOS|Ocean Bio - Operating Profitability|TC BioPharm Ltd - Operating Margin|Operating Return on Sales thirdharmonicbio.com